Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Form 24F-2NT CANTOR FITZGERALD INFRAS For: Mar 31
-
PureCycle Technologies (PCT) Announces $300M Capital Raise
-
PureCycle Announces $300 Million Capital Raise; Outlines Growth Plan for One Billion Pounds of Installed Capacity with Projected EBITDA of $600 Million Per Year By 2030
-
Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)
-
Cantor Fitzgerald Reiterates Overweight Rating on salesforce.com (CRM)
-
Cantor Fitzgerald Reiterates Neutral Rating on Supernus Pharmaceuticals (SUPN)
-
Cantor Fitzgerald Reiterates Overweight Rating on Molina Healthcare (MOH)
-
Cantor Fitzgerald Reiterates Neutral Rating on Humana (HUM)
-
Cantor Fitzgerald Reiterates Overweight Rating on HCA Healthcare Inc (HCA)
-
Cantor Fitzgerald Upgrades CVS Health (CVS) to Overweight
-
Cantor Fitzgerald Reiterates Overweight Rating on Centene (CNC)
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Sizzle Acquisition Corp. II Completes $230,000,000 Initial Public Offering
-
Perpetua Resources Closes US$425 Million Financing as part of Comprehensive Financing Package for Stibnite Gold Project
-
AIRO Announces Closing of Its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Caledonia Mining Corporation Plc: Utilisation of the block admission in respect of ATM Sales Agreement
-
Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
-
Prenetics (PRE) PT Raised to $14 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Neutral Rating on Lucid Group Inc. (LCID)
-
Cantor Fitzgerald Reiterates Neutral Rating on Polestar Automotive Holding Uk Plc (PSNY)
-
Cantor Fitzgerald Reiterates Overweight Rating on Rivian Automotive Inc (RIVN)
-
Cantor Fitzgerald Reiterates Overweight Rating on Archer Aviation Inc. (ACHR)
-
Cantor Fitzgerald Reiterates Overweight Rating on PureCycle Technolgies (PCT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Lab USA (RKLB)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA)
-
Explainer-What are bitcoin treasury strategies, the latest trend in the public markets?
-
Exclusive-US Export-Import Bank considers $120 million loan for Greenland rare earths project
-
Avino Renews ATM Equity Program
-
Exclusive: Airo chairman says strong IPO reflects robust aerospace demand
-
Cantor Fitzgerald Reiterates Overweight Rating on Metsera Inc (MTSR)
-
Prenetics (PRE) PT raised to $14 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Esperion Therapeutics (ESPR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Datadog (DDOG)
-
Cantor Fitzgerald Reiterates Overweight Rating on Freshworks Inc (FRSH)
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
Cantor Fitzgerald Reiterates Overweight Rating on Acadia Pharmaceuticals (ACAD)
-
Cantor Fitzgerald Reiterates Overweight Rating on Celldex Therapeutics (CLDX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Coinbase Global Inc. (COIN)
-
Cantor Fitzgerald Reiterates Overweight Rating on AMD (AMD)
-
Cantor Fitzgerald Reiterates Overweight Rating on Cabaletta Bio Inc. (CABA)
-
Sprott Physical Platinum and Palladium Trust Updates Its “At-the-Market” Equity Program
-
AIRO Announces Pricing of Its Initial Public Offering
-
Form N-CEN CANTOR FITZGERALD INFRAS For: Mar 31
-
Panoro Minerals Ltd. Announces Brokered LIFE Offering for Gross Proceeds of up to C$10 Million
-
Prenetics (PRE) PT Raised to $14 at Cantor Fitzgerald
-
Cantor downgrades air taxi company Joby after sharp stock rally
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
Cantor Fitzgerald Reiterates Overweight Rating on Corvus Pharmaceuticals (CRVS)
-
Cantor Fitzgerald Reiterates Overweight Rating on NewAmsterdam Pharma Co NV (NAMS)
-
Cantor Fitzgerald Reiterates Neutral Rating on Bristol-Myers Squibb Co. (BMY)


